- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
TCR diversity – a universal cancer immunotherapy biomarker? ; volume:4 ; number:1 ; day:15 ; month:11 ; year:2016 ; pages:1-4 ; date:12.2016
Journal for ImmunoTherapy of Cancer ; 4, Heft 1 (15.11.2016), 1-4, 12.2016
- Creator
-
McNeel, Douglas G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-016-0175-4
- URN
-
urn:nbn:de:1111-2016112024065
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McNeel, Douglas G.
- SpringerLink (Online service)
Other Objects (12)
TCR-like antibodies in cancer immunotherapy
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Genetic and environmental determinants of human TCR repertoire diversity
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
TcR
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Genetic and environmental determinants of human TCR repertoire diversity
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
TcR
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Genetic and environmental determinants of human TCR repertoire diversity
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
TcR
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma